Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-02-20 @ 12:55 PM
Study NCT ID:
NCT05623059
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2022-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate Pharmacokinetics and Safety of Slow Release DHEA
Sponsor:
Indiana University
Organization:
Study Overview
Official Title:
Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA
Status:
COMPLETED
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DHEA
Brief Summary:
This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
Detailed Description:
Pharmacokinetic (PK) studies of DHEA in asthma have never been done. In many diseases, PK in subjects with disease differs from that of control subjects and those with other conditions. Therefore, researchers are investigating if PK levels of slow release DHEA are different in subjects with asthma who have the HSD3B1 AA or AC phenotypes
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| P01HL158507 | NIH | None | https://reporter.nih.gov/quic… | View |